IFN (IFN-I and IFN-II) production was impeded in COVID-19 patients with severe illness, and IFN-stimulated genes were downregulated (Blanco-Melo et al., 2020; Hadjadj et al., 2020). This evidence concerns the gene IFNA1 and COVID-19.